Pfizer recalls dopamine injection lot; two Phase 3 trials remain not yet recruitingSep 24Weekly roundup, 4 itemsdopaminePfizer
FDA accepts Axsome's NDA for AXS-12 in narcolepsy cataplexyJul 15Regulatory milestoneAxsome Therapeutics, Inc.
Sign inSign in